We are live on ! Find out more
RCM

Radcliffe Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 1.18%
This Fund
S&P 500
This Quarter Est. Return
-9.24%
1 Year Est. Return
+1.18%
3 Year Est. Return
+4.94%
5 Year Est. Return
-24.37%
10 Year Est. Return
-27.33%
AUM
$4.4B
AUM Growth
+$581M
Cap. Flow
-$25.7M
Cap. Flow %
-0.58%
Top 10 Hldgs %
14.78%
Holding
1,342
New
290
Increased
298
Reduced
33
Closed
125
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WEL.WS
1076
DELISTED
Integrated Wellness Acquisition Corp Redeemable Warrants
WEL.WS
$623K 0.01%
+62,500
New +$22.3K
FAASW
1077
DELISTED
DigiAsia Corp Warrant
FAASW
$622K 0.01%
62,500
PGSS.WS
1078
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
$618K 0.01%
62,500
ADALW
1079
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
$618K 0.01%
62,071
+24,571
+66% +$9.91K
PCPC.WS
1080
DELISTED
Periphas Capital Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $28.75
PCPC.WS
$618K 0.01%
25,199
ARTAW
1081
DELISTED
Artisan Acquisition Corp. Warrants
ARTAW
$603K 0.01%
61,103
THCPW
1082
DELISTED
Thunder Bridge Capital Partners IV, Inc. Warrant
THCPW
$593K 0.01%
60,000
GTPBW
1083
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$587K 0.01%
60,000
GETR.WS
1084
DELISTED
Getaround, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share
GETR.WS
$586K 0.01%
60,000
CNDA
1085
DELISTED
Concord Acquisition Corp II
CNDA
$575K 0.01%
+59,425
New +$576K
HAACW
1086
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$569K 0.01%
+57,740
New +$33.7K
SANB
1087
DELISTED
Sanaby Health Acquisition Corp. I Class A Common Stock
SANB
$563K 0.01%
56,301
+36,301
+182% +$362K
SABSW icon
1088
SAB Biotherapeutics Warrant
SABSW
$104K
$562K 0.01%
55,692
-25,205
-31% -$21.3K
GLS.WS
1089
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
$559K 0.01%
+100,000
New +$23.4K
CHPMW
1090
DELISTED
CHP Merger Corp. Warrant
CHPMW
$559K 0.01%
55,000
ASCAW
1091
DELISTED
A SPAC I Acquisition Corp. Warrant
ASCAW
$554K 0.01%
+56,250
New +$8.36K
AVHI
1092
DELISTED
Achari Ventures Holdings Corp I
AVHI
$552K 0.01%
55,500
+25,000
+82% +$247K
APGNW
1093
DELISTED
Apexigen, Inc. WarrantApexigen, Inc. Warrant
APGNW
$541K 0.01%
53,688
TINV.WS
1094
DELISTED
Tiga Acquisition Corp. Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TINV.WS
$538K 0.01%
52,528
PSQH.WS icon
1095
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.73M
$531K 0.01%
54,879
ANGHW icon
1096
Anghami Inc Warrants
ANGHW
$526K 0.01%
+60,000
New +$41.3K
EOCW.WS
1097
DELISTED
Elliott Opportunity II Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EOCW.WS
$522K 0.01%
+53,400
New +$40K
TPGY.WS
1098
DELISTED
TPG Pace Beneficial Finance Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TPGY.WS
$520K 0.01%
+52,335
New +$35.9K
LVACW
1099
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
$517K 0.01%
51,860
+1,860
+4% +$753
ACAQ
1100
DELISTED
Athena Consumer Acquisition Corp.
ACAQ
$513K 0.01%
+51,392
New +$511K

Similar funds

Radcliffe Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Radcliffe Capital Management held 1,342 positions worth $4.4B, up 15% from $3.82B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Radcliffe Capital Management's Q1 2022 filing shows 290 new, 298 increased, 33 reduced and 125 closed positions. Its largest new stake was Zalatoris Acquisition Corp.: 1,434,939 shares worth $14M. The largest sale was Zalatoris Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one redeemable public warrant, an estimated $14.5M.

By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 40% a quarter earlier, followed by Healthcare and Technology.

  • Radcliffe Capital Management's largest Q1 2022 buy was Zalatoris Acquisition Corp.: 1,434,939 shares worth $14M.
  • Radcliffe Capital Management added most to Bridgetown Holdings Limited Class A Ordinary Shares in Q1 2022, an estimated $12.6M increase.
  • Radcliffe Capital Management's biggest Q1 2022 reduction was Astrea Acquisition Corp. Class A Common Stock, cutting an estimated $977K.
  • Radcliffe Capital Management fully exited Zalatoris Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one redeemable public warrant in Q1 2022, selling an estimated $14.5M.
  • Radcliffe Capital Management's ten largest holdings make up 15% of its $4.4B portfolio in Q1 2022.
  • Radcliffe Capital Management opened 290 new positions and closed 125 in Q1 2022.
  • Radcliffe Capital Management's portfolio value rose 15% quarter-over-quarter to $4.4B.

Based on Radcliffe Capital Management's 13F filing for Q1 2022, filed 16 May 2022.